Enrique Poradosu
2022
In 2022, Enrique Poradosu earned a total compensation of $970.3K as Chief Scientific & Business Officer at Nuvectis Pharma.
Compensation breakdown
| Bonus | $200,000 |
|---|---|
| Salary | $349,072 |
| Stock Awards | $421,200 |
| Total | $970,272 |
Poradosu received $421.2K in stock awards, accounting for 43% of the total pay in 2022.
Poradosu also received $200K in bonus and $349.1K in salary.
Rankings
In 2022, Enrique Poradosu's compensation ranked 3,080th out of 5,676 executives tracked by ExecPay. In other words, Poradosu earned more than 45.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,080 out of 5,676 | 46th |
Division Manufacturing | 1,728 out of 3,084 | 44th |
Major group Chemicals And Allied Products | 814 out of 1,399 | 42nd |
Industry group Drugs | 760 out of 1,300 | 42nd |
Industry Pharmaceutical Preparations | 549 out of 942 | 42nd |
Source: SEC filing on April 29, 2024.
Poradosu's colleagues
We found two more compensation records of executives who worked with Enrique Poradosu at Nuvectis Pharma in 2022.